Boston: Unprecedented Biotech Growth Area
The Greater Boston area has established itself as a world leader in field of life sciences research and drug development. Today there are more than 450 biotech companies there. In last years, biopharma companies is Boston area overstepped more than $5 billion in venture capital investment. Today, there are more than 125,000 biotech R&D jobs and more than 30 million square feet of lab space throughout the state. There is a large pool of expertise and talents with focus on drug discovery and development reaching more than 1.500 drug candidates in development (>15% of the US pipeline) in broad therapeutic areas.
Modern and Automated Facilities
Our brand new, state-of-the-art facilities include R&D labs for cell line development, USP and DSP processes establishment, and analytical support. cGMP manufacturing site with both single-use and stainless steel systems for upstream and downstream process development, formulation, and fill-finish of microbial and mammalian cell culture-based products will be fully functional in 2021. Flexible design with integrated infrastructure enables us to develop, formulate, and manufacture clients’ proteins and antibodies quite fast while aseptic drug product manufacturing capabilities allows adding value to customer project from timelines and cost perspective.
The microbial production line consists of 30L-300L fermenters and mammalian line comprises various single-use bioreactors ranging from 10L to 2000L, with possibility to expand capacity with second 2000L bioreactor.
We are a 30 min drive from the Logan International Airport, which can be easily accessed from all major US cities and many international locations.
